Kalkine Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1โ36
- Matches
- 45
- Sources here
- 16
- Companies here
- 1
Active search
45 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Benchmark reiterates Speculative Buy on Nephros stock after Q2 beat By Investing.com
Benchmark has reiterated its Speculative Buy rating and a $6.00 price target for Nephros (NASDAQ:NEPH) after the company reported strong second-quarter results. Nephros exceeded revenue and earnings expectations with $6.0 million in revenue (up 36% year-over-year) and earnings of $0.11 per share. The positive โฆ
Benchmark reiterates Speculative Buy on Nephros stock after Q2 beat
Benchmark has reiterated its Speculative Buy rating and a $6.00 price target for Nephros (NASDAQ:NEPH) after the company reported strong second-quarter results. Nephros exceeded revenue and earnings expectations with $6.0 million in revenue (up 36% year-over-year) and earnings of $0.11 per share. The positive โฆ
Nephros (NEPH) Q2 2026 Earnings Call Transcript
Nephros (NEPH) reported record Q2 2026 revenue of $6 million, a 36% increase year-over-year, driven by strong growth in core programmatic revenue and a nearly threefold increase in service revenue. The company's net income rose to $1.2 million, significantly boosted by a $600,000 tariff โฆ
Nephros (NEPH) director Arthur Amron granted 2,418 shares, holds 140,874
Nephros Inc. director Arthur H. Amron was granted 2,418 shares of Common Stock on August 12, 2026, as compensation for his board service, increasing his direct holdings to 140,874 shares. He also holds stock options for 7,323 shares fully vested at an exercise price โฆ
Northland Securities Maintains Nephros(NEPH.US) With Hold Rating, Raises Target Price to $4.75
Northland Securities has reiterated its Hold rating on Nephros (NEPH.US) but raised the price target to $4.75. This adjustment indicates a slightly more optimistic outlook on the company's future stock performance by the firm.
August 2026's Promising Penny Stocks
This article highlights three promising penny stocks for August 2026: Nephros (NEPH), Siebert Financial (SIEB), and Douglas Elliman (DOUG). It examines their financial health, recent performance, and strategic initiatives, noting that these companies offer potential for growth despite being smaller or newer entities. The โฆ
NEPHROS INC Q2 2026: Revenue $6.02M, Net income $1.2M, EPS $0.11โ 10-Q Summary
NEPHROS INC reported strong second-quarter 2026 results, with revenue reaching $6.02M and net income soaring to $1.2M, resulting in an EPS of $0.11. The growth was attributed to increased product and service sales, along with improved gross margins due to an IEEPA tariff refund. โฆ
Nephros (NEPH) boosts Q2 2026 profit on revenue growth and tariff refund
Nephros Inc. (NEPH) reported significant financial growth in Q2 2026, with net revenue up 36% to $6.0 million and net income rising to $1.2 million, largely driven by programmatic product growth and a $0.6 million IEEPA tariff refund. Despite this positive performance, the company โฆ
Press Release: Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026
Nephros announced strong financial results for the quarter ended June 30, 2026. The company reported significant revenue growth and improved profitability, driven by strong demand for its innovative filtration products. Management expressed optimism about future growth prospects and their ability to continue delivering value โฆ
Nephros Inc (NEPH) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Nephros Inc (NEPH), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that three analysts rate NEPH as a "Buy" with an average price target of $7.00. The forecast also includes expected โฆ
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ...
Nephros Inc (NEPH) reported record quarterly revenue of $6 million in Q2 2026, a 36% year-over-year increase, along with a significant surge in net income (over 400%) and Adjusted EBITDA (260%). The growth was attributed to broad-based improvements across product and service revenues, and โฆ
Earnings call transcript: Nephros posts Q2 2026 growth, shares rise premarket
Nephros reported record revenue growth and stronger profitability in Q2 2026, with shares rising premarket despite a slight revenue miss. The company highlighted a 36% increase in revenue to $6.0 million and a significant rise in service-only revenue, driven by existing customers buying more โฆ
Nephros details integrated water safety platform while expanding in Greater New York and Puerto Rico
Earnings Call Insights: Nephros, Inc. (NEPH) Q2 2026 MANAGEMENT VIEW * CEO Robert Banks said Q2 2026 was โan exceptional quarterโ as Nephros โgenerated $6 million in revenue, the highest quarterly revenue in our history,โ and added that โrevenue also increased approximately 15% sequentially โฆ
Nephros says its service offerings nearly tripled during Q2
Nephros (Nasdaq: NEPH) reported record second-quarter 2026 net revenue of $6.0 million, a 36% increase year-over-year, with core programmatic revenue growing 27%. The company's service offerings nearly tripled compared to the prior year, reflecting increased customer demand for installation, replacement, and water management support. โฆ
Nephros Q2 2026 Earnings: Revenue Rises 36% as Tariff Refund Lifts Margins
Nephros reported a 36% increase in Q2 2026 net revenue to $6.017 million, with diluted EPS rising to $0.11, significantly boosted by a one-time $0.6 million tariff refund. While the refund inflated profitability, core programmatic revenue still grew 27%, and service-related revenue nearly tripled. โฆ
Nephros to File Q2 Results After Close, Host 4:30 ET Call
Nephros (Nasdaq: NEPH) announced it will file its second-quarter 2026 financial results after market close on Thursday, August 06, 2026. The company will host a conference call on the same day at 4:30 p.m. ET. Dial-in details for domestic and international participants, along with โฆ
Nephros Schedules Second Quarter 2026 Financial Results Conference Call
Nephros, Inc. announced it will file its second quarter financial results on Thursday, August 06, 2026, after market close and will host a conference call on the same day at 4:30 pm ET. The company is a leading water technology provider, offering filtration solutions โฆ
Nephros Inc (NEPH) Financial Health: Profitability & Balance Sheet Analysis
The article provides an analysis of Nephros Inc's (NEPH) financial health, noting its current financial score of 6.42, ranking 125 out of 159 in its industry. The company's financial status is described as robust, with low operating efficiency, and it recently reported a 6.87% โฆ
Nephros, Inc. Revenue Breakdown โ NASDAQ:NEPH
Nephros, Inc. (NASDAQ:NEPH) reported a total revenue of $18.79 million USD last year. The majority of this revenue, $18.23 million USD, was generated from its Water Filtration Products segment, marking an increase from $14.04 million USD the previous year. The United States was the โฆ
Nephros Inc (NEPH) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis for Nephros Inc (NEPH), detailing its current valuation score, P/E ratio, and market data. It highlights that the company's valuation score is 8.25, placing it 75th in its industry, and notes its P/E ratio of 46.43. The analysis โฆ
Nephros Inc (NEPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Nephros Inc (NEPH), detailing its current price momentum score, identified support and resistance levels, and a summary of technical indicators and moving averages. According to the analysis, the stock is currently trading between $3.66 (resistance) and $3.01 โฆ
Nephros Inc (NEPH) Institutional Confidence
Nephros Inc (NEPH) has an institutional shareholding score of 5.00, placing it 96th out of 160 in its industry. The institutional shareholding proportion has increased by 6.10% quarter-over-quarter to 50.96%. James Simons is the largest institutional shareholder, holding 0.92% of outstanding shares.
NEPH|Nephros Inc|Price:3.640|Chg%:-0.130
Nephros Inc. is a water technology company specializing in filtration solutions for medical and commercial markets. The company provides products and services to prevent waterborne pathogens in healthcare settings and improve water quality in commercial sectors like food service and hospitality. Key information includes โฆ
Nephros Inc (NEPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article from TradingKey addresses the revenue breakdown for Nephros Inc (NEPH), detailing business segments, regional revenue, and profit contribution. It states that the relevant financial data for these categories have not yet been disclosed by the company. The page provides a general overview โฆ
Nephros Inc (NEPH) Dividends & Stock Splits: Historical Payouts and Event Timeline
The article provides an overview of Nephros Inc (NEPH) dividends and stock splits. It states that no dividends have been distributed over the past five years. Key financial data like market cap and P/E ratio are also presented.
Nephros Inc (NEPH) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Nephros Inc (NEPH), listing major individual and institutional holders and their respective proportions. It also provides a breakdown of shareholder types, including hedge funds and individual investors, and tracks institutional shareholding changes over several quarters. Key shareholders โฆ
NEPH|Nephros Inc|Price:3.450|Chg%:-0.190
This article provides a comprehensive stock analysis of Nephros Inc (NEPH) based on TradingKey's stock score system. It highlights the company's healthy fundamentals, high growth potential with steady revenue growth, and relatively fair valuation. The analysis also covers institutional ownership, analyst ratings, and a โฆ